drugset / Trial / NCT01407510

HPA Axis Study in Japanese Adults

NCT01407510

Phase 2 Completed 12 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

A multicenter, open-label study to evaluate the adrenal suppression potential of Mapracorat 0.1% ointment in Japanese adults with atopic dermatitis.

Timeline

Start
2011-05-09
Primary completion
2011-09-16
Completion
2012-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Mapracorat Small molecule 0.1 % Topical

Indications